As of 2025-07-19, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.17) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.78 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -109.6%.
The range of the Relative Valuation is (0.10) - (0.23) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.2x - 0.6x | 0.4x |
| Forward P/E multiples | 0.2x - 0.5x | 0.4x |
| Fair Price | (0.10) - (0.23) | (0.17) |
| Upside | -105.7% - -112.9% | -109.6% |
| Date | P/E |
| 2025-07-16 | -3.71 |
| 2025-07-15 | -3.34 |
| 2025-07-14 | -3.54 |
| 2025-07-11 | -3.50 |
| 2025-07-10 | -3.30 |
| 2025-07-09 | -3.52 |
| 2025-07-08 | -3.71 |
| 2025-07-07 | -2.99 |
| 2025-07-04 | -2.51 |
| 2025-07-03 | -2.71 |
| 2025-07-02 | -2.29 |
| 2025-06-30 | -2.27 |
| 2025-06-27 | -2.27 |
| 2025-06-26 | -2.14 |
| 2025-06-25 | -2.03 |
| 2025-06-24 | -2.03 |
| 2025-06-23 | -1.88 |
| 2025-06-20 | -2.10 |
| 2025-06-19 | -2.12 |
| 2025-06-18 | -2.21 |
| 2025-06-17 | -1.94 |
| 2025-06-16 | -1.90 |
| 2025-06-13 | -1.79 |
| 2025-06-12 | -1.68 |
| 2025-06-11 | -1.66 |
| 2025-06-10 | -1.25 |
| 2025-06-09 | -1.29 |
| 2025-06-06 | -1.07 |
| 2025-06-05 | -0.98 |
| 2025-06-04 | -1.01 |
| 2025-06-03 | -1.02 |
| 2025-06-02 | -1.01 |
| 2025-05-30 | -1.01 |
| 2025-05-29 | -1.08 |
| 2025-05-28 | -1.14 |
| 2025-05-27 | -1.22 |
| 2025-05-26 | -1.27 |
| 2025-05-23 | -1.20 |
| 2025-05-22 | -1.22 |
| 2025-05-21 | -1.27 |
| 2025-05-20 | -1.31 |
| 2025-05-16 | -1.42 |
| 2025-05-15 | -1.51 |
| 2025-05-14 | -1.55 |
| 2025-05-13 | -1.57 |
| 2025-05-12 | -1.62 |
| 2025-05-09 | -1.55 |
| 2025-05-08 | -1.57 |
| 2025-05-07 | -1.53 |
| 2025-05-06 | -1.53 |